Effectiveness of First-line Therapy for Small Cell Lung Cancer with IO Chemotherapy

被引:0
|
作者
Grohe, C. [1 ]
机构
[1] Elk Ev Lungenklin, Klin Pneumol, Berlin, Germany
来源
PNEUMOLOGIE | 2022年 / 76卷
关键词
D O I
10.1055/s-0042-1747799
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Po 249
引用
收藏
页码:S49 / S49
页数:1
相关论文
共 50 条
  • [1] Topotecan as first-line therapy for small cell lung cancer
    Greco, FA
    LUNG CANCER, 2003, 41 : S9 - S16
  • [2] Clinical Effectiveness of First-Line Immunotherapy in Small Cell Lung Cancer
    Lee, M.
    Zhang, F.
    Cheng, H.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S694 - S695
  • [3] First-line chemotherapy in metastatic small-cell lung cancer (SCLC)
    Wolf, M
    Tebbe, S
    Fink, T
    LUNG CANCER, 2004, 45 : S223 - S234
  • [5] First-Line Systemic Therapy for Non-Small Cell Lung Cancer
    Heist, Rebecca S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 59 - +
  • [7] COST-EFFECTIVENESS OF FIRST-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Yang, M. C.
    Tan, E. C. H.
    VALUE IN HEALTH, 2014, 17 (07) : A736 - A736
  • [8] Cost-effectiveness of pembrolizumab as first-line therapy for advanced non-small cell lung cancer
    Georgieva, Mina
    da Silveira Nogueira Lima, Joao P.
    Aguiar, Pedro
    Lopes, Gilberto de Lima, Jr.
    Haaland, Benjamin
    LUNG CANCER, 2018, 124 : 248 - 254
  • [9] Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Non-Small Cell Lung Cancer
    Georgieva, M.
    Aguiar, P., Jr.
    Lima, J. P.
    Haaland, B.
    Lopes, G.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2148 - S2149
  • [10] Cost-effectiveness of benmelstobart and anlotinib plus chemotherapy as first-line therapy for extensive-stage small cell lung cancer in China
    Chunyan Yan
    Zhengxiong Li
    Jiayan Li
    Quan Zhao
    Wenxiu Cao
    Shuqing Li
    Ruigang Diao
    Scientific Reports, 15 (1)